Novocure Ltd. (NVCR) Social Stream



Novocure Ltd. (NVCR): $57.17

0.35 (+0.62%)

POWR Rating

Component Grades

Growth

S

Value

I

Momentum

G

Stability

N

Sentiment

U

Quality

P

NOVOCURE LTD (NVCR) Price Targets From Analysts

The tables below show price targets and recommendations from analysts covering NOVOCURE LTD.

Date Number of Analysts Highest Target Price Lowest Target Price Average Target Price Current Price Upside Potential
2021-11-02 7 $200 $85 $151.5 $58.45 159.2%
2022-01-03 8 $200 $82 $141.571 $58.45 142.21%
2022-01-06 8 $200 $82 $134.428 $58.45 129.99%
2022-01-11 8 $200 $45 $112.285 $58.45 92.1%
2022-01-20 8 $200 $45 $112.285 $58.45 92.1%
2022-02-02 9 $200 $45 $110.5 $58.45 89.05%
2022-02-08 9 $200 $45 $120.444 $58.45 106.06%
2022-02-25 9 $200 $45 $114.777 $58.45 96.37%
2022-05-08 9 $200 $45 $114.333 $58.45 95.61%
2022-05-13 9 $200 $45 $111.555 $58.45 90.86%
2022-06-06 10 $200 $45 $111.9 $58.45 91.45%
2022-07-11 9 $200 $45 $113.444 $58.45 94.09%
2022-07-29 9 $200 $45 $110.111 $58.45 88.38%
2022-08-02 7 $200 $45 $98.875 $58.45 69.16%
2022-10-24 7 $200 $45 $96.375 $58.45 64.88%
2022-10-28 7 $200 $45 $94.125 $58.45 61.04%
2022-11-29 8 $200 $43 $96.25 $58.45 64.67%
2022-12-06 8 $200 $43 $96.125 $58.45 64.46%
2022-12-22 8 $200 $43 $96.5 $58.45 65.1%
2023-01-06 8 $200 $65 $107.428 $58.45 83.79%
2023-01-12 8 $200 $65 $111.142 $58.45 90.15%
2023-01-17 8 $200 $65 $112.571 $58.45 92.59%
2023-02-23 7 $130 $65 $97.166 $58.45 66.24%

The Trend in the Analyst Price Target


NVCR's average price target has moved down $94.83 over the prior 19 months.

NVCR reports an average of 34.08% for its upside potential over the past 43 weeks.

Date Number of Analysts Highest Target Price Lowest Target Price Average Target Price Share Price Upside Potential
2022-12-06 8 200 43 96.125 73.48 30.82%
2022-12-22 8 200 43 96.500 79.78 20.96%
2022-12-22 8 200 43 98.571 79.78 23.55%
2023-01-06 8 200 65 111.857 109.04 2.58%
2023-01-12 8 200 65 111.142 95.70 16.14%

NVCR Broker Recommendations Summary

Average Broker Rating Strong Buy Buy Hold Sell Strong Sell Analysts Issuing Recs
3 2 0 3 2 2 7

The Trend in the Broker Recommendations


NVCR's average broker recommendation rating worsened by 1.25 over the prior 35 months.

The points below can provide you with additional insight regarding what the price target and recommendations metrics in the table above mean for investors.

  • To contextualize these metrics, consider that out of all US stocks, NOVOCURE LTD's variance in analysts' estimates is lower than -2643.87% of them.
  • NOVOCURE LTD's number of analysts covering the stock is higher than 550.68% of stocks in the large market cap category.
  • NOVOCURE LTD's upside potential (average analyst target price relative to current price) is greater than 2409.24% of stocks in the large market cap category.
  • NVCR has a higher average analyst price target than 2391.62% of Healthcare stocks.

In terms of price targets and recommendations offered by analysts, the stocks in the Medical Equipment industry with the ratings most similar to NOVOCURE LTD are PODD, DXCM, and RMD.

Is NVCR a Buy, Hold or Sell? See the POWR Ratings now!


Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!




Page generated in 0.7082 seconds.